When modern-day pharmaceutical company Genomics unearths diaries describing the torture of Bedlam inmates, the company's scientists suspect a link between Gaelan and an unnamed inmate. Gaelan and Genomics geneticist Anne Shawe are powerfully drawn to each other, and her family connection to his manuscript leads to a stunning revelation. Will it bring ruin or redemption?
The Apothecary’s Curse by Barbara Barnett is definitely a mix of genres, both classic and modern. The story follows two main characters struggling with immortality: Simon Bell, once a physician, now an author writing about Sherlock Holmes, and Gaelan Erceldoune, former apothecary, currently a bookstore owner. In the past, Bell attempted suicide multiple times, while Erceldoune was captured and tortured by a mad scientist. Eventually the two unite and spend centuries searching for an ancient manuscript that might hold the key to reversing the elixirs which turned them both immortal. Not only does the book contain the secrets of alchemy, but it’s the only remaining link to Erceldoune’s long-lost family.
The storyline moves back and forth in time, delivering the backstory in pieces. At first, the pace is slow and frustrating, but as more mysteries are discovered, readers are drawn further into a spectacular web of conspiracies and drama. The glimpses from the past explain how Bell and Erceldoune come to know one another, while also explaining their shared affliction. The moments in present time reveal the danger of history repeating itself in the form of a corrupt pharmaceutical company hunting down Erceldoune.
I enjoyed the intrigue throughout the story, both in their past lives, as well as their present circumstances. When Erceldoune crosses paths with the geneticist Dr. Shawe, the addition of her character brings just the right twist, leading to an unexpected ending. I was so enthralled by the mix of drama and suspense, I had to read the novel in one sitting.
I think anyone who enjoys mystery-thrillers will enjoy this book.
As always,
AstraDaemon
No comments:
Post a Comment